Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 35 (1) , 51-58
Abstract
No abstract availableKeywords
Funding Information
- La Jolla Pharmaceutical Company
This publication has 23 references indexed in Scilit:
- Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device ImplantationJournal of the American Heart Association, 2018
- Vasoplegia After Cardiovascular Procedures—Pathophysiology and Targeted TherapyJournal of Cardiothoracic and Vascular Anesthesia, 2018
- Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case seriesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2017
- Angiotensin II for the Treatment of Vasodilatory ShockNew England Journal of Medicine, 2017
- Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac SurgeryAnesthesiology, 2017
- Angiotensin II in septic shockCritical Care, 2015
- Methylene Blue is Associated With Poor Outcomes in Vasoplegic ShockJournal of Cardiothoracic and Vascular Anesthesia, 2013
- Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational studyIntensive Care Medicine, 2012
- Early On–Cardiopulmonary Bypass Hypotension and Other Factors Associated With Vasoplegic SyndromeCirculation, 2009
- Association between vasopressor dependence and early outcome in patients after cardiac surgeryAnaesthesia, 2006